Skip to main content
Caplight Logo









Brevel

Brevel

Private
IsraelHealthcare & Life Scienceshttps://brevel.co.il/

Last Round

Grant

Jun 23, 2026

Total Funding Raised

$69.56M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Brevel is a biotechnology company that develops an illuminated fermentation platform to produce sustainable, high-quality microalgae protein for the food, nutrition, and pharmaceutical industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

microalgae proteinfermentation platformplant-based proteinalt-proteinilluminated fermentationfood technatural food colorantbiomanufacturingplant cell cultureprecision fermentationsustainable ingredientsbiotech ingredientsCPG ingredientsnovel foodsB2B food supply

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Brevel Comparables

Compare Brevel with similar companies based on industry and business-model similarity.

Brevel comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sophie's Bionutrients
88%
Aliga Microalgae
86%
Solmeyea
84%

Brevel Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 23, 2026
SeedMar 24, 2025
SeedJul 25, 2023
SeedJun 1, 2023
GrantApr 1, 2018

Key People

Founding team and executive leadership

Ido Golan

Co-Founder and CTO

Founding Team

Yonatan Golan

CEO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 1518% MoM.

  • Jun 23, 2026

    $1M grant from Israel Innovation Authority

Brevel Filings

Explore SEC and related filing metadata, where available.

Brevel filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Brevel's valuation, stock price, and market status.

Is Brevel a public or private company?

Brevel is a private company.

What is the current stock price of Brevel?

Brevel is a private company, so its shares have no public market price. Caplight tracks Brevel's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Brevel worth (valuation)?

Valuation information for Brevel is not publicly available.

Can I buy Brevel stock?

Brevel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Brevel's last funding round?

Brevel's most recent funding round was Grant on June 23, 2026.

Who are the main investors in Brevel?

Key investors in Brevel include NevaTeam Partners, The Food Tech Lab.

Will Brevel IPO soon?

No public IPO plans have been announced for Brevel.

How can I track Brevel secondary market activity?

Caplight tracks bids, offers, and trades in Brevel's shares on secondary markets.

Firmographic Details

HeadquartersIsrael
Employee Range24
Year Founded2017
Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?